Article title: Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil
Authors: Singh AK, Mishra SK, Mishra G, Maurya A, Awasthi R, Yadav MK, Atri N, Pandey PK and Singh SK
Journal: Drug Development and Industrial Pharmacy
Bibliometrics: Volume 46, Number 01, pages 8–19
DOI: 10.1080/03639045.2019.1698594
The following below were the corrections for the published paper:
On page 10, in the right column under “Determination of amyloid formation inhibition (lysozyme fibrillation and fluorescence measurement)” there is an error in the sentence “The fluorescence intensities were measured at 312 nm”. This sentence should be read as “The fluorescence intensities were measured at 485 nm (λmax 435 nm)”.
Similarly next to the above paragraph under “Acetylcholine esterase (AChE) activity assay” there is an error in the sentence “The absorbance of incubated (25 °C, 1 h) DZ and LAPDZ test samples was measured at 312 nm”. This sentence should be read as “The absorbance of incubated (25 °C, 1 h) DZ and LAPDZ test samples was measured at 412 nm”
The same error appears on page 16 in the legend of Figure 9; the correct legend for Figure 9 is: “Percent AChE activities with inhibitors (DZ and LAPDZ 1 mm) obtained at 412 nm. One-way ANOVA using Newman–Keuls multiple comparison test. ***indicate significant differentiate with p < 0.0001. Data presents mean ± SD (n = 3).”
This article is available both online and in print. The online version has been corrected.